2013 – 2014
– College student research mentor
2011 – 2014 Vanderbilt University School of Medicine, Center for Human Genetics Research, PhD committee member.
Now: Postdoctoral fellow at University of Michigan
Now: Postdoctoral fellow at University of Michigan
Dr. Theobald received her medical degree from the Medical College of Virginia and completed her residency and chief residency in Internal Medicine at Vanderbilt University. Following residency, she completed both a Quality Scholars fellowship at the Nashville VA and her Masters in Public Health from Vanderbilt University. Her research and teaching interests focus on improving the safety of care transitions, teaching quality improvement skills and helping providers integrate evidence-based medicine into bedside care. She has been recognized for excellence in teaching ambulatory medicine as well as for her work evaluating the implementation of various improvement initiatives.
Organizations:
Society for General Internal Medicine
American College of Physicians
2011 – 2012
Cecelia Theobald, MD – Dept of Medicine Chief Resident, Research mentor
Now: Assistant Professor, Vanderbilt University
HUGH JACKSON MORGAN TEACHING AWARDS - Best Faculty Teacher, Ambulatory
Dr. Daniel Stover is a medical oncologist in Boston, Massachusetts and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He received his medical degree from Vanderbilt University School of Medicine and has been in practice for 7 years. He is one of 98 doctors at Brigham and Women's Hospital and one of 116 at Dana-Farber Cancer Institute who specialize in Medical Oncology.
Now: Heme-Onc Fellow, Dana Farber Cancer Institute
Award:
Publications:
2009 – 2012
Dan Stover, MD – Dept of Medicine Chief Resident, Research mentor
Now: Heme-Onc Fellow, Dana Farber Cancer Institute
Dr. Van Driest’s research program uses large data sources such as electronic medical records and DNA sequences to predict and improve children’s response to medication (personalized pediatrics).
Sara Van Driest is an Associate Professor of Pediatrics (Division of General Pediatrics) and Medicine (Division of Clinical Pharmacology) at Vanderbilt University Medical Center. She completed her MD and PhD at the Mayo Clinic College of Medicine followed by Pediatric residency and Clinical Pharmacology fellowship at Vanderbilt. As a physician-scientist, Dr. Van Driest uses clinically-generated data and specimens for research and as a tool for implementation of pediatric personalized medicine. She is focused on improving the dosing and understanding the effects of commonly used medications, including antibiotics, analgesics and sedatives. Funding for her research work comes from the National Institutes of Health (NIH) institutes of Child Health and Human Development (NICHD), General Medical Sciences (NIGMS), and Human Genome Research (NHGRI). Dr. Van Driest also was awarded an early career award from the PhRMA Foundation, an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund, and a Doris Duke Clinical Scientist Development Award. Dr. Van Driest is a member of the Society for Pediatric Research and serves on the Scientific Advisory Board for PharVar, a central repository for pharmacogenomic variation. She was the 2019 recipient of the Leon I. Goldberg Early Investigator Award from the American Society for Clinical Pharmacology and Therapeutics.
Pharmacogenomics, precision medicine, electronic health records, drug safety
2011 – 2013
Mary Davis – Vanderbilt University School of Medicine, Center for Human Genetics Research, PhD committee member
Selected Publications
Presentations
Davis MF, Haines JL, Denny JC. Genetic Enrichment of Multiple Sclerosis Risk Loci in Multiple Sclerosis Patients with Co-Morbid Diseases. American Society for Human Genetics Annual Meeting. San Diego, CA. 2014 .
Now: Assistant Professor, BYU
Peters interest is in pharmacogenetics and personalized medicine. Ongoing projects aim to delineate the genetic basis of adverse drug events such as drug induced long QT syndrome and Torsades des pointes using next-generation sequencing methods.
2011 – Present
Peter Weeke, MD - Vanderbilt University School of Medicine, Dept of Clinical Pharmacology, Post-doctoral research mentor
Dr. Blanquicett received his undergraduate degree in Biological Sciences from Florida International University, where he assisted with Gambusia Fish genetic and ARMD research studies. He attended Medical School at Meharry Medical College. During medical school, he employed bioinformatics tools to attempt to predict the patients who are susceptible to developing heparin-induced thrombocytopenia, at Vanderbilt University. Dr. Blanquicett received his PhD degree from the University of Alabama-Birmingham, where he conducted pharmacogenomic and molecular oncology studies. He completed his Post-Doctoral training at Emory University. Dr. Blanquicett more recently participated in the HIV Vaccine Trials Network Research and Mentorship Grant, at Vanderbilt University. Dr. Blanquicett is interested in focusing on molecularly-targeted therapeutics and markers of tumor response, in particular, as applied to solid tumors. He also intends on participating in medical missions, when possible.
2010 – 2012
Carmelo Blanquitt – Meharry Medical School, Research mentor
Shane Stenner, MD, MS, is an Instructor of Biomedical Informatics, with a joint appointment in the Department of Medicine, in the School of Medicine at Vanderbilt University. Dr. Stenner is currently the project director of RxStar, the outpatient electronic prescribing system of the Vanderbilt University Medical Center (VUMC), and project director for the Vanderbilt Outpatient Order Management system (VOOM). His research, and affiliated publications, define generic substitution clinical decision support through novel user-interface changes in electronic prescribing systems, approaches to natural language processing of medication lists and patient text messages about medications, tools to automate mobile phone and web-based medication self-management systems, and innovative uses of patient portal sites.
Dr. Stenner is an ABIM Board Certified physician who remains clinically active. He currently supervises Internal Medicine clinic residents and sees his own clinic patients one day per week, using the clinical tools that he helps to develop. At home, Shane enjoys spending time with his singer-songwriter wife Hillary, son Tobin and 150 lb horse/dog George.
He received his M.D. from Johns Hopkins University and his M.S. in biomedical informatics from Vanderbilt University.
Shane Stenner, MD, MS - Vanderbilt University School of Medicine, Dept of Biomedical Informatics, Masters thesis committee (chair)
Now: Assistant Professor, VUMC